Songming Huang Selected Research

UK-383,367

12/2019

BMP1 inhibitor UK383,367 attenuates renal fibrosis and inflammation in CKD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Songming Huang Research Topics

Disease

24	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 05/2011
23	Inflammation (Inflammations) 07/2021 - 01/2014
14	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 05/2014
12	Fibrosis (Cirrhosis) 11/2021 - 07/2012
10	Ureteral Obstruction 11/2021 - 01/2014
9	Proteinuria 01/2021 - 06/2011
9	Kidney Diseases (Kidney Disease) 05/2018 - 01/2014
8	Neoplasms (Cancer) 01/2022 - 10/2013
8	Chronic Renal Insufficiency 11/2021 - 09/2014
7	Albuminuria 06/2018 - 04/2014
4	Hypoxia (Hypoxemia) 01/2021 - 01/2018
4	Anemia 01/2021 - 01/2018
4	Type 2 Diabetes Mellitus (MODY) 05/2016 - 02/2014
3	Obesity 02/2021 - 09/2015
3	Hypertension (High Blood Pressure) 01/2021 - 01/2016
3	Ischemia 01/2021 - 05/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2017
3	Wounds and Injuries (Trauma) 01/2018 - 01/2015
3	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2017 - 01/2013
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2016 - 01/2013
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2021 - 01/2017
2	Sclerosis 01/2021 - 01/2017
2	Bartter Syndrome (Syndrome, Bartter) 01/2020 - 10/2018
2	Polyuria 01/2020 - 10/2016
2	Hyperaldosteronism (Conn Syndrome) 01/2020 - 10/2018
2	Alkalosis 01/2020 - 10/2018
2	Atherosclerosis 01/2020 - 10/2019
2	Vascular System Injuries 05/2019 - 01/2017
2	Necrosis 01/2019 - 01/2019
2	Diabetic Nephropathies (Diabetic Nephropathy) 04/2014 - 01/2014
2	Infections 04/2014 - 10/2012
2	Insulin Resistance 01/2013 - 10/2012
1	Body Weight (Weight, Body) 02/2021
1	Bites and Stings (Sting) 01/2021

Drug/Important Bio-Agent (IBA)

10	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2017
9	RotenoneIBA 12/2019 - 01/2014
8	AldosteroneIBA 07/2021 - 05/2011
8	Dinoprostone (PGE2)FDA Link 11/2018 - 01/2015
7	Pharmaceutical PreparationsIBA 01/2021 - 01/2017
6	InflammasomesIBA 07/2021 - 09/2014
5	manganese(III)-tetrakis(4-benzoic acid)porphyrinIBA 01/2022 - 04/2015
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2011
5	AlbuminsIBA 01/2019 - 04/2015
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2016 - 07/2012
4	Adenosine Triphosphate (ATP)IBA 01/2022 - 06/2014
4	celastrolIBA 02/2021 - 01/2018
4	roxadustatIBA 01/2021 - 01/2018
4	nephrinIBA 01/2017 - 01/2012
4	NPHS2 proteinIBA 01/2017 - 01/2012
3	LipidsIBA 02/2021 - 01/2018
3	Angiotensin IIIBA 01/2021 - 01/2016
3	superoxide dismutase 2IBA 01/2021 - 01/2018
3	Mitochondrial DNA (mtDNA)IBA 01/2021 - 06/2014
3	Caspase 3 (Caspase-3)IBA 01/2021 - 07/2019
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 06/2011
3	CollagenIBA 12/2019 - 05/2018
3	ProstaglandinsIBA 05/2018 - 10/2016
3	SodiumIBA 01/2018 - 07/2015
3	AngiotensinogenIBA 01/2016 - 04/2014
3	CytokinesIBA 04/2015 - 07/2010
3	Calcitriol Receptors (Calcitriol Receptor)IBA 03/2014 - 01/2013
2	Therapeutic UsesIBA 01/2022 - 01/2021
2	Sirtuin 1IBA 07/2021 - 07/2012
2	AntioxidantsIBA 01/2021 - 02/2014
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 12/2019
2	CilomilastIBA 01/2020 - 01/2020
2	Chloride Channels (Chloride Channel)IBA 01/2020 - 10/2018
2	Insulin (Novolin)FDA Link 12/2019 - 01/2013
2	Fibronectins (Fibronectin)IBA 12/2019 - 05/2018
2	Malondialdehyde (Propanedial)IBA 01/2019 - 07/2014
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2019 - 01/2018
2	Aquaporins (Water Channels)IBA 01/2018 - 10/2016
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 01/2018
2	Interleukin-18 (Interleukin 18)IBA 01/2018 - 01/2017
2	EnzymesIBA 10/2017 - 01/2016
2	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 01/2017 - 01/2016
2	SeleniumIBA 05/2016 - 12/2014
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2016 - 09/2015
2	SaltsIBA 01/2016 - 07/2015
2	CreatinineIBA 01/2015 - 10/2012
2	methyl 4-azidophenylacetimidate (APAI)IBA 03/2014 - 03/2014
2	Triglycerides (Triacylglycerol)IBA 01/2013 - 10/2012
1	2- ((7- nitrobenzo(c)(1,2,5)oxadiazol- 4- yl)thio)pyridine 1-oxideIBA 01/2022
1	4-phenylbutyric acid (Buphenyl)FDA Link 01/2022
1	Aurora Kinase AIBA 11/2021
1	4- (3- chloro- 2- fluorophenoxy)- 1- ((6- (1,3- thiazol- 2- ylamino)pyridin to 2-yl)methyl) cyclohexanecarboxylic acidIBA 11/2021
1	NAD (NADH)IBA 07/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2021
1	LeptinIBA 02/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	InterferonsIBA 01/2021
1	Dimethyl FumarateIBA 01/2021
1	benzoylcarbonyl- aspartyl- glutamyl- valyl- aspartyl- fluoromethyl ketoneIBA 01/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021

Therapy/Procedure

9	Therapeutics 02/2021 - 01/2016
3	Nephrectomy 01/2021 - 01/2016
2	Aftercare (After-Treatment) 01/2020 - 06/2011
1	Fecal Microbiota Transplantation 02/2021
1	Length of Stay 01/2021